Purchase Order 75N90021P00526
Award Date 6/28/21
Potential Completion Date 7/15/21
Potential Value $253K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded Miltenyi Biotec, Inc. a $365,751 firm fixed price contract for the provision of a CliniMACS Prodigy Instrument with installation and training services. The solicitation sought the CliniMACS system, which is a closed loop, fully automated cell isolation system with pre-programmed selection and depletion protocols, to be used in the new Center for Cellular Engineering cGMP Facility located in...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $158,220 firm-fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the delivery and installation qualification of two CliniMACS Plus instruments. The purchase supports the NIH Clinical Center's Center for Cellular Engineering, an AABB-accredited cell therapy laboratory that provides manufacturing services for over 50 intramural clinical...
- Miltenyi Biotec, Inc. was awarded a firm fixed price purchase order totaling $23,700 by the Department of Health and Human Services National Institutes of Health Clinical Center. The award is for CLINIMACS PRODIGY ESSENTIAL SERVICE to be delivered to the agency's location in Bethesda, Maryland by February 14, 2025. Miltenyi Biotec will serve as the prime contractor to provide proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for preventative maintenance of four CliniMACS Prodigy and five CliniMACS Plus cell processing instruments used in the Center for Cellular Engineering's cell therapy production facility. The $112,267 contract provides maintenance services from May 10, 2021 through September 23, 2022 to...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, to provide three replacement CliniMACS Plus instruments with installation and qualification packages. The CliniMACS Plus is a proprietary cell isolation system used by the Clinical Center's Cell Processing Section to manufacture purified cell products for over 50 intramural clinical trials under...
- The U.S. National Institutes of Health (NIH) Clinical Center awarded a $71,087 firm fixed-price purchase order to Miltenyi Biotec, Inc. to provide preventative maintenance services for the agency's CliniMACS Prodigy cell processing instruments through June 1, 2026. This contract does not have a set-aside designation. Miltenyi Biotec is a global manufacturer of biomedical research and cell therapy products, including the CliniMACS line of automated cell isolation systems used by the NIH's Cell...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $248,000.00 fixed-price purchase order to Miltenyi Biotec, Inc., a global biotechnology company, for CliniMACS PLUS reagents and consumables used in the manufacture of human cell and tissue-based products for clinical trials and therapies. The NIH Clinical Center, which is responsible for producing specialized immunotherapy products for critically ill patients, requires these proprietary...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The $7,009 contract supports the delivery and installation of Miltenyi Biotec's CliniMACS Prodigy cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, to acquire a Miltenyi ClinicMACS Prodigy device for $249,369.00. The Prodigy is an automated, closed-system cell processing instrument that will support preclinical and translational studies of novel cell therapies within the NIH's Pediatric Oncology Branch and Center for Cellular Engineering. This...